ICAM-1 mediates the inhibitory effects of hyaluronan on IL-1 induced MMP production in RA synovial fibroblasts via down-regulation of NF-kB and p38.

被引：0
|
作者：
Ito, Hiromu
Hiramitsu, Teruko
Yasuda, Tadashi
Nakamura, Takashi
机构：
[1] Kyoto Univ, Grad Sch, Kyoto, Japan
[2] Tenri Univ, Tenri, Nara, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S213 / S213
页数：1
相关论文
共 25 条
  • [21] Luteolin suppresses IL-1β-induced cytokines and MMPs production via p38 MAPK, JNK, NF-kappaB and AP-1 activation in human synovial sarcoma cell line, SW982
    Choi, Eun Mi
    Lee, Young Soon
    FOOD AND CHEMICAL TOXICOLOGY, 2010, 48 (10) : 2607 - 2611
  • [22] Intracellular IL-1 Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-κB pathways
    Garat, C
    Arend, WP
    CYTOKINE, 2003, 23 (1-2) : 31 - 40
  • [23] Down-regulation of MiR-138-5p Protects Chondrocytes ATDC5 and CHON-001 from IL-1 β-induced Inflammation Via Up-regulating SOX9
    He Chunlei
    Zhao Chang
    Liu Sheng
    Zhong Yanchun
    Liu Luling
    Cai Daozhang
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (43) : 4613 - 4621
  • [24] The interplay of TapSAKI and NEAT-1 as potential modulators in gentamicin-induced acute kidney injury via orchestrating miR-22-3p/ TLR4/MyD88/NF-KB/IL-1 β milieu: Novel therapeutic approach of Betanin
    Abd-Elmawla, Mai A.
    Elsamanoudie, Nourhan M.
    Ismail, Manal Fouad
    Hammam, Olfat Ali
    El Magdoub, Hekmat M.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [25] 7b, a novel naphthalimide derivative, exhibited anti-inflammatory effects via targeted-inhibiting TAK1 following down-regulation of ERK1/2-and p38 MAPK-mediated activation of NF-κB in LPS-stimulated RAW264.7 macrophages
    Shao, Jin
    Li, Yiquan
    Wang, Ziyuan
    Xiao, Mengmeng
    Yin, Peihao
    Lu, Yanhua
    Qian, Xuhong
    Xu, Yufang
    Liu, Jianwen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 17 (02) : 216 - 228
123